saxenda a glp 1 (Liraglutide) GLP-1 injection Saxenda vs. Ozempic: Comparing Medications

Bossi, F., et al

18 aa) of the GLP-1R, comprised of both coded and non-coded amino acids, are described in the current study

Additionally, iron overload may enhance platelet aggregation and thrombosis, increasing the risk of acute coronary events ( Conversely, iron deficiency can similarly exert negative effects on cardiovascular function

The GLP-1 era is therefore accelerating portfolio discipline decisions that many companies were already overdue to make, which means the question is not really whether to rationalize but whether to do it on the companys own terms or under duress

4 More recently, the FDA Reauthorization Act of 2017 (FDARA) made a reference encouraging the enrollment of more diverse patient populations, and the Final Rule for Clinical Trials Registration and Results Information Submission (42 CFR Part 11) went into effect in January 2017

While this move doesnt reinstate compounding access, it signals that regulators may be re-evaluating their stance by late 2024 or 2025